The health care burden of patients with epilepsy in the United States: an analysis of a nationwide database over 15 years

2012 ◽  
Vol 32 (3) ◽  
pp. E1 ◽  
Author(s):  
Andrew C. Vivas ◽  
Ali A. Baaj ◽  
Selim R. Benbadis ◽  
Fernando L. Vale

Object The aim of this study was to analyze the national health care burden of patients diagnosed with epilepsy in the US and to analyze any changes in the length of stay, mean charges, in-hospital deaths (mortality), and disposition at discharge. Methods A retrospective review of the Nationwide Inpatient Sample (NIS) database for epilepsy admissions was completed for the years from 1993 to 2008. The NIS is maintained by the Agency for Healthcare Research and Quality and represents a 20% random stratified sample of all discharges from nonfederal hospitals within the US. Patients with epilepsy were identified using ICD-9 codes beginning with 345.XX. Approximately 1.1 million hospital admissions were identified over a span of 15 years. Results Over this 15-year period (between 1993 and 2008), the average hospital charge per admission for patients with epilepsy has increased significantly (p < 0.001) from $10,050 to $23,909, an increase of 137.9%. This is in spite of a 33% decrease in average length of stay from 5.9 days to 3.9 days. There has been a decrease in the percentage of in-hospital deaths by 57.9% and an increase in discharge to outside medical institutions. Conclusions The total national charges associated with epilepsy in 2008 were in excess of $2.7 billion (US dollars, normalized). During the studied period, the cost per day for patients rose from $1703.39 to $6130.51. In spite of this drastic increase in health care cost to the patient, medical and surgical treatment for epilepsy has not changed significantly, and epilepsy remains a major source of morbidity.

2020 ◽  
Vol 38 (15_suppl) ◽  
pp. e20513-e20513
Author(s):  
Krishna Rekha Moturi ◽  
Prasanth Lingamaneni ◽  
Ishaan Vohra ◽  
Binav Baral ◽  
Muhammad Zain Farooq ◽  
...  

e20513 Background: Patients with Multiple Myeloma (MM) are at risk for developing sepsis due to defective humoral immunity, underlying disease factors like renal failure, iron overload, and treatment with immunosuppressive agents. Sepsis is a significant cause of morbidity and mortality in patients with MM. In this study, we aimed to study trends of inpatient outcomes and health care burden of patients with sepsis in MM. Methods: Adult patients with MM admitted to the hospital from 2012 to 2017 were identified from the Nationwide Inpatient Sample database and were stratified into two groups based on the diagnosis of sepsis. Multivariate regression analysis was used to adjust for confounders when calculating for mortality. Statistical tests for trends of mortality, length of stay and hospital charges were performed. Results: A total of 513,615 patients with MM met the inclusion criteria. Sepsis was found to be the most common cause of admission amongst these patients (12.2%) and of the patients with MM who died in the hospital, 38.1% carried the primary diagnosis of sepsis. Mean age of the patients was 70.1 years and they were predominantly Caucasian (62.1%) with male preponderance (57.7%). MM patients admitted with sepsis were found to have higher mortality (15.7 and 3.5% P < 0.0001),higher hospital costs (22,082$ vs 15,206; P < 0.0001) and longer hospital stays (8.1 days vs 6.0 P < 0.0001) when compared to those admitted for other reasons. Temporal trends have been noted to improve over the years, with mortality decreasing from 18% to 13.1%, (p trend < 0.001). Length of stay (in days) decreased from 8.3 to 7.7 days (p trend = 0.009) and hospital charges (in dollars) decreased from 22,407 to 21,209 (p trend < 0.001). Conclusions: Although the improving trends are promising, sepsis still continues to be significantly contributing to morality and morbidity in patients with MM. Measures to identify the changing spectrum of infectious diseases, their predisposing risk factors along with strategies to recognize and prevent early stages of sepsis could have a significant impact on lowering mortality and health care burden. [Table: see text]


2020 ◽  
Vol 31 (3) ◽  
pp. S273-S274
Author(s):  
J. Moon ◽  
M. Konstantinidis ◽  
S. Fordyce ◽  
C. Stark ◽  
A. Herr ◽  
...  

2015 ◽  
Vol 21 (10) ◽  
pp. 965-972 ◽  
Author(s):  
Alpesh Amin ◽  
Amanda Bruno ◽  
Jeffrey Trocio ◽  
Jay Lin ◽  
Melissa Lingohr-Smith

Hepatology ◽  
2016 ◽  
Vol 64 (6) ◽  
pp. 2165-2172 ◽  
Author(s):  
Alina M. Allen ◽  
W. Ray Kim ◽  
James P. Moriarty ◽  
Nilay D. Shah ◽  
Joseph J. Larson ◽  
...  

2014 ◽  
Vol 17 (3) ◽  
pp. A174
Author(s):  
L. Wang ◽  
L. Xie ◽  
L. Li ◽  
Y. Wang ◽  
J. Du ◽  
...  

2018 ◽  
Vol 39 (3) ◽  
pp. 201-211 ◽  
Author(s):  
Paul Williams ◽  
Abhishek Kavati ◽  
Dominic Pilon ◽  
Yongling Xiao ◽  
Maryia Zhdanava ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document